Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 29 | 2025 | 268 | 5.500 |
Why?
|
| Chest Pain | 8 | 2025 | 49 | 4.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 30 | 2025 | 547 | 3.880 |
Why?
|
| Anxiety | 9 | 2025 | 847 | 2.100 |
Why?
|
| Acute Coronary Syndrome | 3 | 2021 | 43 | 1.800 |
Why?
|
| Patient Satisfaction | 3 | 2025 | 163 | 1.250 |
Why?
|
| Humans | 69 | 2026 | 42163 | 0.890 |
Why?
|
| Adult | 39 | 2026 | 13458 | 0.830 |
Why?
|
| Needs Assessment | 1 | 2025 | 180 | 0.810 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2025 | 577 | 0.790 |
Why?
|
| Middle Aged | 30 | 2026 | 11819 | 0.780 |
Why?
|
| Female | 43 | 2026 | 24018 | 0.700 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 38 | 0.700 |
Why?
|
| Male | 38 | 2026 | 22779 | 0.690 |
Why?
|
| Anxiety Disorders | 3 | 2023 | 319 | 0.690 |
Why?
|
| Prospective Studies | 13 | 2026 | 1574 | 0.650 |
Why?
|
| Young Adult | 22 | 2026 | 4936 | 0.630 |
Why?
|
| Pain | 4 | 2023 | 283 | 0.590 |
Why?
|
| Sex Factors | 5 | 2025 | 1008 | 0.590 |
Why?
|
| Hospitalization | 3 | 2021 | 482 | 0.560 |
Why?
|
| Stress, Psychological | 3 | 2019 | 641 | 0.560 |
Why?
|
| Fear | 3 | 2025 | 271 | 0.540 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2017 | 3 | 0.530 |
Why?
|
| Longitudinal Studies | 15 | 2025 | 1020 | 0.530 |
Why?
|
| Amiodarone | 1 | 2016 | 2 | 0.530 |
Why?
|
| Lidocaine | 1 | 2016 | 16 | 0.520 |
Why?
|
| Cardiology Service, Hospital | 1 | 2016 | 3 | 0.500 |
Why?
|
| Survivors | 5 | 2025 | 152 | 0.500 |
Why?
|
| Health Services Research | 1 | 2016 | 161 | 0.480 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 79 | 0.470 |
Why?
|
| Risk Assessment | 4 | 2025 | 845 | 0.470 |
Why?
|
| Reward | 2 | 2024 | 106 | 0.420 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 242 | 0.400 |
Why?
|
| Accidents, Traffic | 6 | 2022 | 46 | 0.400 |
Why?
|
| Aged | 12 | 2026 | 7982 | 0.400 |
Why?
|
| Heart Rate | 2 | 2024 | 261 | 0.400 |
Why?
|
| Adolescent | 13 | 2025 | 5950 | 0.380 |
Why?
|
| Delphi Technique | 2 | 2025 | 30 | 0.370 |
Why?
|
| United States | 7 | 2025 | 5072 | 0.360 |
Why?
|
| Comorbidity | 3 | 2025 | 725 | 0.340 |
Why?
|
| Wounds and Injuries | 2 | 2021 | 191 | 0.320 |
Why?
|
| Pain Measurement | 2 | 2025 | 181 | 0.310 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2025 | 27 | 0.310 |
Why?
|
| Alcohol Drinking | 2 | 2025 | 585 | 0.310 |
Why?
|
| Risk Factors | 8 | 2024 | 3942 | 0.300 |
Why?
|
| Wrist | 3 | 2024 | 7 | 0.300 |
Why?
|
| Amygdala | 3 | 2024 | 125 | 0.300 |
Why?
|
| Mental Disorders | 2 | 2024 | 377 | 0.290 |
Why?
|
| Indiana | 4 | 2025 | 16 | 0.290 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2026 | 74 | 0.290 |
Why?
|
| Brain | 7 | 2024 | 1452 | 0.290 |
Why?
|
| Prefrontal Cortex | 3 | 2024 | 160 | 0.290 |
Why?
|
| Cross-Sectional Studies | 8 | 2025 | 3077 | 0.280 |
Why?
|
| Sex Characteristics | 2 | 2024 | 253 | 0.280 |
Why?
|
| Depression | 7 | 2023 | 837 | 0.280 |
Why?
|
| Motor Vehicles | 6 | 2023 | 15 | 0.280 |
Why?
|
| Estradiol | 2 | 2025 | 269 | 0.260 |
Why?
|
| Opioid-Related Disorders | 2 | 2022 | 188 | 0.260 |
Why?
|
| Sleep | 2 | 2026 | 179 | 0.260 |
Why?
|
| Electronic Health Records | 2 | 2025 | 99 | 0.250 |
Why?
|
| Wakefulness | 1 | 2026 | 23 | 0.240 |
Why?
|
| Multicenter Studies as Topic | 1 | 2025 | 61 | 0.240 |
Why?
|
| Galvanic Skin Response | 1 | 2025 | 16 | 0.230 |
Why?
|
| Prevalence | 3 | 2025 | 1597 | 0.230 |
Why?
|
| Autonomic Nervous System | 1 | 2025 | 38 | 0.230 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2025 | 52 | 0.220 |
Why?
|
| Natural Language Processing | 1 | 2024 | 21 | 0.220 |
Why?
|
| Crisis Intervention | 1 | 2024 | 9 | 0.220 |
Why?
|
| Panic Disorder | 1 | 2025 | 102 | 0.220 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 70 | 0.220 |
Why?
|
| Waiting Lists | 1 | 2024 | 39 | 0.220 |
Why?
|
| Demography | 1 | 2024 | 195 | 0.220 |
Why?
|
| Patient-Centered Care | 1 | 2025 | 73 | 0.210 |
Why?
|
| Income | 1 | 2025 | 160 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 358 | 0.210 |
Why?
|
| Cohort Studies | 3 | 2025 | 1729 | 0.210 |
Why?
|
| Internal Capsule | 1 | 2023 | 3 | 0.200 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 89 | 0.200 |
Why?
|
| Retrospective Studies | 6 | 2021 | 2485 | 0.200 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 25 | 0.200 |
Why?
|
| Comparative Effectiveness Research | 1 | 2022 | 15 | 0.200 |
Why?
|
| Histamine Antagonists | 1 | 2022 | 6 | 0.200 |
Why?
|
| Cardiology | 1 | 2022 | 19 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 10 | 0.190 |
Why?
|
| Mental Health Services | 1 | 2024 | 134 | 0.190 |
Why?
|
| Benzodiazepines | 1 | 2022 | 19 | 0.190 |
Why?
|
| Dissociative Disorders | 1 | 2022 | 18 | 0.190 |
Why?
|
| Blood Vessels | 1 | 2002 | 36 | 0.190 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 59 | 0.190 |
Why?
|
| Alcoholism | 1 | 2025 | 292 | 0.180 |
Why?
|
| Child Abuse | 1 | 2023 | 90 | 0.180 |
Why?
|
| Telemedicine | 1 | 2025 | 215 | 0.180 |
Why?
|
| Residence Characteristics | 1 | 2024 | 359 | 0.180 |
Why?
|
| Social Support | 1 | 2024 | 438 | 0.180 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.180 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 128 | 0.170 |
Why?
|
| Exercise Test | 1 | 2021 | 75 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 101 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2021 | 280 | 0.170 |
Why?
|
| Coronary Angiography | 1 | 2021 | 97 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2002 | 106 | 0.170 |
Why?
|
| Burnout, Professional | 1 | 2021 | 25 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2021 | 44 | 0.170 |
Why?
|
| Blood Pressure | 1 | 2024 | 662 | 0.170 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 261 | 0.160 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 5 | 0.160 |
Why?
|
| Models, Theoretical | 1 | 2021 | 230 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 471 | 0.160 |
Why?
|
| Neck Injuries | 1 | 2019 | 10 | 0.160 |
Why?
|
| Asphyxia | 1 | 2019 | 7 | 0.160 |
Why?
|
| Psychometrics | 1 | 2021 | 350 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 680 | 0.150 |
Why?
|
| Anti-Anxiety Agents | 1 | 2018 | 17 | 0.140 |
Why?
|
| Ventricular Fibrillation | 1 | 2016 | 9 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2016 | 14 | 0.130 |
Why?
|
| Probability | 1 | 2017 | 82 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2016 | 52 | 0.130 |
Why?
|
| Bundle-Branch Block | 1 | 2016 | 3 | 0.120 |
Why?
|
| Tachycardia | 1 | 2016 | 11 | 0.120 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 45 | 0.120 |
Why?
|
| North Carolina | 1 | 2016 | 122 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 825 | 0.120 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 1995 | 21 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2016 | 184 | 0.110 |
Why?
|
| Lignans | 1 | 1995 | 22 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2014 | 33 | 0.110 |
Why?
|
| Acute Disease | 1 | 2014 | 156 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 587 | 0.110 |
Why?
|
| Isoflavones | 1 | 1995 | 132 | 0.110 |
Why?
|
| Gender Identity | 1 | 2014 | 117 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 146 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1001 | 0.100 |
Why?
|
| Texas | 1 | 2014 | 428 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1139 | 0.100 |
Why?
|
| Psychopathology | 2 | 2023 | 20 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 573 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 541 | 0.090 |
Why?
|
| Public Health | 1 | 2014 | 405 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1989 | 16 | 0.080 |
Why?
|
| Diet | 1 | 1995 | 810 | 0.070 |
Why?
|
| Time Factors | 2 | 2024 | 1848 | 0.070 |
Why?
|
| Prognosis | 2 | 2021 | 850 | 0.070 |
Why?
|
| Pregnancy | 4 | 2024 | 1737 | 0.070 |
Why?
|
| Liver | 1 | 1989 | 503 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2024 | 121 | 0.050 |
Why?
|
| Anisotropy | 1 | 2023 | 33 | 0.050 |
Why?
|
| Biological Availability | 1 | 2023 | 115 | 0.050 |
Why?
|
| Feces | 1 | 2023 | 126 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 30 | 0.050 |
Why?
|
| Vertigo | 1 | 2022 | 2 | 0.050 |
Why?
|
| Consensus | 1 | 2022 | 53 | 0.050 |
Why?
|
| Nerve Net | 1 | 2023 | 96 | 0.050 |
Why?
|
| Membranes, Artificial | 1 | 2002 | 33 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 303 | 0.050 |
Why?
|
| Polyglycolic Acid | 1 | 2002 | 48 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2021 | 3 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2021 | 14 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 10 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2021 | 31 | 0.050 |
Why?
|
| Fluid Therapy | 1 | 2021 | 29 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 708 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2002 | 110 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 314 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2021 | 13 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 157 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 385 | 0.040 |
Why?
|
| Life Change Events | 1 | 2021 | 107 | 0.040 |
Why?
|
| Critical Care | 1 | 2021 | 48 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 50 | 0.040 |
Why?
|
| Polymers | 1 | 2002 | 151 | 0.040 |
Why?
|
| Bacteremia | 1 | 2021 | 37 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 71 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 73 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 1221 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 591 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2023 | 960 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 245 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 115 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 2019 | 5 | 0.040 |
Why?
|
| Neck | 1 | 2019 | 20 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2019 | 35 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 251 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 234 | 0.040 |
Why?
|
| Violence | 1 | 2019 | 133 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 109 | 0.040 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 104 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2017 | 36 | 0.030 |
Why?
|
| Veterans | 1 | 2019 | 203 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 415 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 141 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 1995 | 21 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 1995 | 16 | 0.030 |
Why?
|
| Animals | 3 | 2002 | 16695 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 1995 | 40 | 0.030 |
Why?
|
| Plant Preparations | 1 | 1995 | 25 | 0.030 |
Why?
|
| Plants | 1 | 1995 | 114 | 0.030 |
Why?
|
| Child | 1 | 2022 | 3381 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 458 | 0.020 |
Why?
|
| Hormones | 1 | 1991 | 56 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1991 | 28 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1989 | 132 | 0.020 |
Why?
|
| Orchiectomy | 1 | 1989 | 38 | 0.020 |
Why?
|
| Ovariectomy | 1 | 1989 | 128 | 0.020 |
Why?
|
| Reference Values | 1 | 1989 | 207 | 0.020 |
Why?
|
| Organ Size | 1 | 1989 | 167 | 0.020 |
Why?
|
| Maternal Age | 1 | 1987 | 34 | 0.020 |
Why?
|
| Prolactin | 1 | 1987 | 64 | 0.020 |
Why?
|
| Parity | 1 | 1987 | 60 | 0.020 |
Why?
|
| Androgens | 1 | 1987 | 107 | 0.020 |
Why?
|
| Estrogens | 1 | 1987 | 202 | 0.010 |
Why?
|
| Rats | 1 | 1989 | 3701 | 0.010 |
Why?
|
| Pregnanediol | 1 | 1991 | 5 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1991 | 17 | 0.010 |
Why?
|
| Estrone | 1 | 1991 | 21 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1991 | 53 | 0.010 |
Why?
|
| Pregnancy Trimester, First | 1 | 1991 | 21 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 1991 | 32 | 0.010 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1987 | 1 | 0.000 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1987 | 2 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1987 | 62 | 0.000 |
Why?
|
| Dehydroepiandrosterone | 1 | 1987 | 11 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1987 | 44 | 0.000 |
Why?
|
| Testosterone | 1 | 1987 | 211 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1987 | 1679 | 0.000 |
Why?
|